|
To put the economic value into your technology’s performance, contact Presscott Associates today! |
TECHNO-ECONOMIC STUDIESWe add the value of economics to the science of life. Clinical efficacy will always be the key to market adoption and positive health plan coverage decisions, but cost-effectiveness and/or the demonstration of “economic value” can add an important dimension to your product’s dossier. This is particularly true if the current standard of care is well accepted and less expensive than your proposed alternative. As more health plans formally integrate |
|
For these reasons (or if you are simply unsure of how your technology fits in economically), Presscott Associates should be the choice to work with your team to:
– Retrospective studies using proprietary data sources available through provider or health plan partners
– Retrospective studies using public data sources along with your own field data – Prospective studies during your product’s investigative stages in which economic data is collected during FDA clinical trials – Prospective studies on a post-market basis as needed to facilitate market adoption and optimal health plan coverage and reimbursement parameters (see Revenue Chain Management)
|
